Observational studyBMC urology2016

Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy.

Shimpei Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.